Influence of maternal infections on neonatal acute phase proteins and their interaction in the development of non-affective psychosis

Translational Psychiatry

Volumn 5, Issue 2, 2015, Pages

  Blomstrom A ^a   Gardner, R M ^a   Dalman, C ^a   Yolken, R H ^b   Karlsson, H ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 2 MACROGLOBULIN; FIBRINOGEN; IMMUNOGLOBULIN G ANTIBODY; MATERNAL ANTIBODY; PROCALCITONIN; SERUM AMYLOID P; TISSUE PLASMINOGEN ACTIVATOR; IMMUNOGLOBULIN G; PROTOZOON ANTIBODY; VIRUS ANTIBODY;

ARTICLE; CHRONIC DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENVIRONMENTAL EXPOSURE; FIBRINOGEN BLOOD LEVEL; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MATERNAL DISEASE; NEWBORN; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; PSYCHOSIS; SCHIZOPHRENIA; TOXOPLASMA GONDII; TOXOPLASMOSIS; ADOLESCENT; ADULT; CASE CONTROL STUDY; CYTOMEGALOVIRUS INFECTIONS; FEMALE; IMMUNOLOGY; MALE; METABOLISM; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE; PSYCHOTIC DISORDERS; RISK; SWEDEN; TOXOPLASMA; YOUNG ADULT;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOGLOBULIN G; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOTIC DISORDERS; RISK; SCHIZOPHRENIA; SWEDEN; TOXOPLASMA; TOXOPLASMOSIS; YOUNG ADULT;

EID: 84927731876     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.142     Document Type: Article

References (36)

1. Dauby N, Goetghebuer T, Kollmann TR, Levy J, Marchant A. Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections. Lancet Infect Dis 2012; 12: 330-340.
2. Kankova S, Sulc J, Krivohlava R, Kubena A, Flegr J. Slower postnatal motor development in infants of mothers with latent toxoplasmosis during the first 18 months of life. Early Hum Dev 2012; 88: 879-884.
3. Blomstrom A, Karlsson H, Wicks S, Yang S, Yolken RH, Dalman C. Maternal antibodies to infectious agents and risk for non-affective psychoses in the offspring-a matched case-control study. Schizophr Res 2012; 140: 25-30.
4. Mortensen PB, Pedersen CB, Hougaard DM, Norgaard-Petersen B, Mors O, Borglum AD et al. A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring. Schizophr Res 2010; 122: 257-263.
5. Brown AS, Schaefer CA, Quesenberry CP Jr., Liu L, Babulas VP, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 2005; 162: 767-773.
6. Buka SL, Cannon TD, Torrey EF, Yolken RH. Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol Psychiatry 2008; 63: 809-815.
7. Mortensen PB, Norgaard-Pedersen B, Waltoft BL, Sorensen TL, Hougaard D, Torrey EF et al. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry 2007; 61: 688-693.
8. Gardner RM, Dalman C, Wicks S, Lee BK, Karlsson H. Neonatal levels of acute phase proteins and later risk of non-affective psychosis. Transl Psychiatry 2013; 3: e228.
9. de Villiers WJ, Louw JP, Strachan AF, Etsebeth SM, Shephard EG, de Beer FC. Creactive protein and serum amyloid A protein in pregnancy and labour. Br J Obstet Gynaecol 1990; 97: 725-730.
10. Forsgren M, Skoog E, Jeansson S, Olofsson S, Giesecke J. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS 1994; 5: 113-116.
11. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and-sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 1990; 69: 19-36.
12. Ahlfors K, Ivarsson SA, Harris S. Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature. Scand J Infect Dis 1999; 31: 443-457.
13. Forsgren M, Gille E, Ljungstrom I, Nokes DJ. Toxoplasma gondii antibodies in pregnant women in Stockholm in 1969, 1979, and 1987. Lancet 1991; 337: 1413-1414.
14. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol 2005; 20: 575-579.
15. Marchant A, Goldman M. T cell-mediated immune responses in human newborns: ready to learn Clin Exp Immunol 2005; 141: 10-18.
16. Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 1999; 104: 55-60.
17. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003; 289: 203-209.
18. Silveira C, Ferreira R, Muccioli C, Nussenblatt R, Belfort R Jr. Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier. Am J Ophthalmol 2003; 136: 370-371.
19. Suzuki Y, Sa Q, Gehman M, Ochiai E. Interferon-gamma-and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain. Expert Rev Mol Med 2011; 13: e31.
20. Elkington R, Walker S, Crough T, Menzies M, Tellam J, Bharadwaj M et al. Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol 2003; 77: 5226-5240.
21. de Metz J, Hack CE, Romijn JA, Levi M, Out TA, ten Berge IJ et al. Interferongamma in healthy subjects: selective modulation of inflammatory mediators. Eur J Clin Invest 2001; 31: 536-543.
22. Tse DB, Young BK. Co-ordinate expression of Th1/Th2 phenotypes in maternal and fetal blood: evidence for a transplacental nexus. J Perinat Med 2012; 40: 165-170.
23. Muller N, Wagner JK, Krause D, Weidinger E, Wildenauer A, Obermeier M et al. Impaired monocyte activation in schizophrenia. Psychiatry Res 2012; 198: 341-346.
24. Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C et al. Meta-analysis of genome-wide association studies in 480 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 2011; 123: 731-738.
25. Ladenvall P, Nilsson S, Jood K, Rosengren A, Blomstrand C, Jern C. Genetic variation at the human tissue-type plasminogen activator (tPA) locus: haplotypes and analysis of association to plasma levels of tPA. Eur J Hum Genet 2003; 11: 603-610.
26. Sabater-Lleal M, Huang J, Chasman D, Naitza S, Dehghan A, Johnson AD et al. Multiethnic meta-analysis of genome-wide association studies in 4100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease. Circulation 2013; 128: 1310-1324.
27. Brown AS, Hooton J, Schaefer CA, Zhang H, Petkova E, Babulas V et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 2004; 161: 889-895.
28. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Wagner RL, Yolken RH. Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 2001; 15: 411-420.
29. Canetta S, Sourander A, Surcel HM, Hinkka-Yli-Salomaki S, Leiviska J, Kellendonk C et al. Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort. Am J Psychiatry 2014; 171: 960-968.
30. Moraru M, Cisneros E, Gomez-Lozano N, de Pablo R, Portero F, Canizares M et al. Host genetic factors in susceptibility to herpes simplex type 1 virus infection: contribution of polymorphic genes at the interface of innate and adaptive immunity. J Immunol 2012; 188: 4412-4420.
31. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421-427.
32. Seo HS, Mu R, Kim BJ, Doran KS, Sullam PM. Binding of glycoprotein Srr1 of Streptococcus agalactiae to fibrinogen promotes attachment to brain endothelium and the development of meningitis. PLoS Pathog 2012; 8: e1002947.
33. Luo D, Lin JS, Parent MA, Mullarky-Kanevsky I, Szaba FM, Kummer LW et al. Fibrin facilitates both innate and T cell-mediated defense against Yersinia pestis. J Immunol 2013; 190: 4149-4161.
34. Blomstrom A, Karlsson H, Svensson A, Frisell T, Lee BK, Dal H et al. Hospital admission with infection during childhood and risk for psychotic illness-a population-based cohort study. Schizophr Bull 2013; 40: 1518-1525.
35. Nielsen PR, Benros ME, Mortensen PB. Hospital contacts with infection and risk of schizophrenia: a population-based cohort study with linkage of Danish National Registers. Schizophr Bull 2013; 40: 1526-1532.
36. Benros ME, Nielsen PR, Nordentoft M, Eaton WW, Dalton SO, Mortensen PB. Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry 2011; 168: 1303-1310.